Search the Newsreel

Dream Accelerates Growth of Asset Management Platform With Acquisition of Chancerygate, a Leading U.K.-Based Industrial Asset Manager and Developer

Combined platform is one of Europe's leaders in urban industrial with over 80 professionals and 27 million square feet of GLA managed or under development across nine countries. TORONTO & LONDON, July 30, 2026--(BUSINESS WIRE)--Dream Unlimited Corp. ("Dream") (TSX: DRM) today announced that Dream …

Dream Industrial REIT Announces Entry Into U.K. Multi-Let Industrial Market and Growth of Strategic Private Ventures in Europe

Cromwell Park, Bredbury, UK - 72,000 sq ftEastside, Manchester, UK - 60,000 sq ftL'Alter Business Park, Valencia, Spain - 217,000 sq ftAxis Park - Milton Keynes, Golden Triangle, UKWorld Freight Terminal – Manchester, UKQuestor - Dartford, Southeast UKAirport Trade Park - Dublin, Ireland This …

[10-Q] Dream Finders Homes, Inc. Quarterly Earnings Report

Dream Finders Homes, Inc. (DFH) has filed its unaudited quarterly report (Form 10-Q) for the period ending June 30, 2026, revealing financial results and operational updates. The report indicates an increase in total debt compared to December 31, 2025, and a reduction in Class …

Dream Finders Homes Q2 revenue falls to $1.06 billion

Dream Finders Homes: Q2 Earnings Snapshot

Dream Finders net sales rise 15% as net income falls to $28M

Dream Finders Homes announced its second quarter 2026 financial results, reporting a 15% increase in net sales to 2,232, and a 3% rise in home closings to 2,290. Despite these gains, net income attributable to DFH fell to $28 million from $57 million in …

Rainbow Children's Medicare Q1 profit rises 13% as revenue jumps 33%

Dream Finders Homes Shares Drop After Posting Lower Q2 Earnings, Revenue

Dream Finders Homes (NYSE:DFH) Posts Earnings Results

CVKD|Cadrenal Therapeutics Inc|Price:2.065|Chg%:+0.095

This article provides a detailed financial overview of Cadrenal Therapeutics Inc (CVKD), including its current stock price, market capitalization, key financial figures, and recent performance trends. It highlights the company's biopharmaceutical focus, particularly on its lead investigational product tecarfarin, and includes analyst ratings, peer …

(DFH) and the Role of Price-Sensitive Allocations

This article analyzes Dream Finders Homes Inc. Class A (NYSE: DFH) using AI models, identifying strong near-term sentiment despite persistent mid and long-term weakness. It provides specific institutional trading strategies (Position, Momentum Breakout, Risk Hedging) with entry/target/stop-loss zones and highlights key support and resistance …

Dream Office Real Estate Investment Trst (TSE:D.UN) Share Price Crosses Above Two Hundred Day Moving Average - Time to Sell?

Behavioral Patterns of CDRE and Institutional Flows

This article analyzes Cadre Holdings Inc. (NASDAQ: CDRE) using AI models, indicating strong near and mid-term sentiment but a weak long-term outlook. It identifies a mid-channel oscillation pattern and an exceptional risk-reward setup targeting a 22.7% gain. The piece outlines three institutional trading strategies—Position, …

CDRE|Cadre Holdings Inc|Price:33.370|Chg%:+0.560

Cadre Holdings Inc (CDRE) is currently trading at $33.370, up 1.71%, with a market cap of $1.43 billion. The company, which manufactures safety products for law enforcement and military, shows healthy fundamentals and high growth potential, though its technical indicators suggest sideways trading despite …

Enterprise value to EBIT forward of Cadre Holdings, Inc. – NYSE:CDRE

This article focuses on the "Enterprise value to EBIT forward" metric for Cadre Holdings, Inc. (NYSE: CDRE). It appears to be a financial data point presented by TradingView, indicating a specific valuation ratio for the company's stock.

Andrew Peller Limited Announces ISS Recommendation That Shareholders Vote for the Proposed Arrangement With Fairfax

Andrew Peller Limited ISS cites premium cash consideration, certainty of value, immediate liquidity and the Special Committee process in recommending shareholders vote FOR the Arrangement Your vote is important – vote well in advance of the proxy deadline: Friday August 7, 2026 at 10:00 …

Cadrenal Therapeutics Inc (CVKD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides a revenue breakdown for Cadrenal Therapeutics Inc (CVKD). It indicates that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. The page also includes current stock information such as price, …

Cadrenal Therapeutics Inc (CVKD) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis for Cadrenal Therapeutics Inc (CVKD), including its PE, PB, and fair value. It displays current stock prices, market capitalization, and links to financial and analytical overviews. The content also lists various resources such as company information and community …

Cadre Holdings : CDRE

Cadre Holdings Inc (CDRE) specializes in safety and survivability equipment for high-risk situations, offering solutions like body armor, survival suits, and law enforcement tools. The article provides current stock data for CDRE, noting its stock price and market capitalization. It also references a recent …

JPMorgan initiates Cadre Holdings stock at Overweight on safety platform By Investing.com

JPMorgan initiated coverage on Cadre Holdings Inc. (NYSE:CDRE) with an Overweight rating and a $40 price target, citing the company's strong position as a mission-driven safety platform. Despite a recent 26% stock decline and a Q1 2026 earnings miss, JPMorgan believes the market underappreciates …

J.P. Morgan Initiates Cadre Holdings(CDRE.US) With Buy Rating, Announces Target Price $40

J.P. Morgan has initiated coverage of Cadre Holdings (CDRE.US) with a 'Buy' rating. The firm has set a target price of $40 for the stock. This initiation indicates a positive outlook from J.P. Morgan on Cadre Holdings' future performance.

CVKD|Cadrenal Therapeutics Inc|Price:1.830|Chg%:-0.030

This article provides a detailed financial overview of Cadrenal Therapeutics Inc (CVKD), including its current stock price, market capitalization, key financial figures, and recent performance trends. It highlights the company's biopharmaceutical focus, particularly on its lead investigational product tecarfarin, and includes analyst ratings, peer …

Godrej Agrovet Q1 Results: Earnings Call Scheduled for August 6

Andretti Acquisition Corp. II Today's Market Trends | POLE Stock Real-Time Quotes, Trading Strategies & Related Analysis | TradingKey

This article provides a market overview for Andretti Acquisition Corp. II (POLE), including its current stock price, market capitalization, key financial figures, and technical indicators. It outlines the company's blank check purpose and lists its major shareholders. The article also includes frequently asked questions …

Cadre Holdings Inc (CDRE) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Cadre Holdings Inc (CDRE), listing its major shareholders and institutional holdings. It provides information on the proportion of shares held by various entities, including individual investors, investment advisors, and hedge funds, as well as institutional holding trends …

Dream Finders Homes, Inc. Revenue Breakdown – NYSE:DFH

Cadre Holdings (CDRE) Affirms Dividend, Is It Still 34% Undervalued?

Cadre Holdings (CDRE) recently affirmed a quarterly dividend of US$0.10 per share. Despite a year-to-date share price decline of 24.95%, the company is considered 34.1% undervalued by Simply Wall St. analysis, which pegs its fair value at $46.80 against a closing price of $30.86. …

Cadrenal Therapeutics Inc (CVKD) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Cadrenal Therapeutics Inc (CVKD) focusing on various indicators and moving averages. It offers insights into the stock's support and resistance levels, and the implications of different technical signals (Buy, Sell, Neutral) from tools like MACD, RSI, and …

Cadre Holdings Inc (CDRE) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides a historical overview of Cadre Holdings Inc. (CDRE) dividends, detailing past and upcoming payout dates, record dates, payment dates, and ex-dividend dates. It shows that the company has distributed a total of 50.21 million USD in dividends over the past five …

Cadre Holdings Inc (CDRE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Cadre Holdings Inc (CDRE), detailing its regional revenue contributions. The company's revenue is largely derived from the United States, accounting for 75.60%, with International markets contributing 24.40%. The article notes that business segment and profit contribution data …

Cadrenal Therapeutics Market Sentiment

This article analyzes the market sentiment for Cadrenal Therapeutics (CVKD) based on analyst consensus, short interest, options flow, and insider activity. Key signals show a "Buy" consensus from analysts, 3.1% short float indicating bearish sentiment, no options flow data, and "Net Seller" insider activity …

Cadrenal Therapeutics Inc (CVKD) Cash Flow Statement

This article provides the quarterly and annual cash flow statements for Cadrenal Therapeutics Inc (CVKD), detailing operating, investing, and financing cash flows. It also includes frequently asked questions explaining different types of cash flow and Cadrenal Therapeutics Inc's performance in these areas. Investors can …

Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation

Cadrenal Therapeutics has initiated a partnering process for its Cardiac Acute Critical Care Franchise, following a landmark data presentation at ISTH 2026. The company is seeking strategic out-licensing, portfolio monetization, or commercial co-development partnerships for its late-stage assets, CAD-1005, frunexian, and tecarfarin. This move …

CVKD|Cadrenal Therapeutics Inc|Price:2.040|Chg%:+0.010

This article provides a detailed financial overview of Cadrenal Therapeutics Inc (CVKD), including its stock price, market capitalization, and key financial statements such as the income statement, balance sheet, and cash flow statement. It highlights the company's latest earnings report, future forecasts, and quarterly …

PLCE|Children's Place Inc|Price:2.410|Chg%:-0.230

Children's Place Inc (PLCE) is trading at $2.41, down 8.71%, with a market cap of $53.59 million. The company's fundamentals are considered relatively weak with good growth potential, and its valuation is fairly valued within the Specialty Retailers industry. Analysts currently rate the stock …

Godrej Agrovet Limited (NSE:GODREJAGRO) Looks Like A Good Stock, And It's Going Ex-Dividend Soon